воскресенье, 25 сентября 2016 г.

Allergan wins Fda approval to market new Natrelle Inspira Cohesive breast implants

Allergan wins Fda approval to market new Natrelle Inspira Cohesive breast implants


Allergan plc today announced the company has received approval from the U.S. Food and Drug Administration to market NATRELLE INSPIRA Cohesive breast implants, offering women undergoing reconstruction, augmentation or revision surgery a new breast shaping option that combines a high gel fill ratio and Allergan's highly cohesive gel for a customized result. The new NATRELLE INSPIRA Cohesive line of breast implants is the newest entry into the category of breast implants commonly referred to as "gummy" implants, designed for women who are interested in increased breast fullness.



from Biotech News